FDA issues guidance on compounding certain beta-lactam products in shortage
The FDA has releasedÂ
Stay updated with breaking news from Pharmacy Compounding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has releasedÂ
The start of cold and flu season has led to a spike in respiratory illness and also a shortage of amoxicillin oral suspension. Hospitals and some pharmacies would like to be able to compound amoxicillin suspension from commercially available amoxicillin tablets or capsules.
This annual award recognizes excellence and leadership in pharmacy compounding....
In a Sept.16 letter to National Association of Boards of Pharmacy CEO Al Carter, FDA states that desiccated thyroid extract products can put patients at harm and that therapies containing DTE require a biologics license application. The letter encouraged NABP to share the letter with its members, the state boards of pharmacy. Carter relayed the information to boards of pharmacy on Sept. 22.
After last month’s Energy and Commerce Committee dust-up over the future of CURES 2.0 Lauren had a question for the legislation’s Republican champion.